Rather recently proposed revisions in the reference interval for normal ALT levels may further impair its use as a biomarker, as a decreased upper normal limit yields higher numbers of false positives, while still showing too low sensitivity for use in cases of liver fibrosis. Here, GPT is linked to Hepatic fibrosis.